Riskpilot← Back to searchSign inGet full accessKemecoda AB
ABIn liquidationOrg 5568727399General medical practice activities · NACE 8621Est. 20111 employees
Revenue 2025
SEK 0
EBITDA margin
—
-8% vs 2024
Equity ratio
93.4%
Financial strength
Net profit 2025
SEK 1,4M
+297% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -44K | -8% |
| Net profit | SEK 1,4M | +297% |
| Total assets | SEK 1,6M | -65% |
| Equity | SEK 1,5M | -66% |
| Employees | 1 | — |
Legal name
Kemecoda AB
Org number
5568727399
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 november 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva medicinsk konsultation, utbildning och egen mottagningsverksamhet, försäljning av data, leksaker, kläder och delikatesser samt annan därmed förenlig verksamhet.
Address
Email
frank.lange@talenom.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −36 | −33 | −31 | −41 | −44 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −36 | −33 | −31 | −41 | −44 |
| Net financials | — | — | 1 | −1 | 1 452 |
| Profit before tax | −7 | 328 | 270 | 458 | 1 408 |
| Tax | −0 | −73 | −62 | −104 | — |
| Net profit | −7 | 255 | 208 | 355 | 1 408 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 149 | 4 933 | 4 730 | 4 405 | 1 562 |
| Equity | 3 988 | 4 059 | 4 080 | 4 240 | 1 458 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 0 | 73 | 151 | 166 | 104 |
| Total debt | — | 73 | 151 | 166 | 104 |
EBITDA margin
-4393300.0%
This company
15.8%
Market median
-27805796% vs market
20212025
Equity ratio
93.4%
This company
38.2%
Market median
+145% vs market
20212025
Return on equity
96.5%
This company
18.4%
Market median
+424% vs market
20212025
Net profit margin
140789800.0%
This company
8.1%
Market median
+1738145579% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MN Chief Executive Officer | Chief Executive Officer | 2020 |
FI Liquidator | Liquidator | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kemecoda AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maud Nina Maria Kendorf | Chief Executive Officer | 0 companies |
| Frank Ingemar Lange | Liquidator | 0 companies |
| Göran Bertil Kendorf | Board of Directors | 0 companies |
| Britta Elisabeth Kendorf | Deputy Board Member | 0 companies |